Pharmacological targeting of cancer-associated fibroblasts in pancreatic cancer
Rémi Samain(Inserm), Corinne Bousquet(Centre National de la Recherche Scientifique), Aurélie Perraud(Centre Hospitalier Universitaire de Limoges), Christine Jean(Centre National de la Recherche Scientifique), Stéphanie Cassant‐Sourdy(Université Toulouse III - Paul Sabatier), Stéphane Pyronnet(Centre National de la Recherche Scientifique), David C. Muller(UNSW Sydney), Herbert Schmid(Novartis (Switzerland)), Julia Rochotte(Université Toulouse III - Paul Sabatier), Yvan Martineau(Centre National de la Recherche Scientifique), Muriel Mathonnet(Inserm)
Cited by 0
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
|Proceedings of the National Academy of Sciences|1999|290
Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
|The Journal of Pathology|2018|284